Furthermore, during melanoma progression, the expression of CD40L on tumor-infiltrating CD4+ T cells, as well as the expression of interferon (IFN-)γ, tumor necrosis factor (TNF-)α, and IL-2 by these cells, was inhibited, accompanied by increased numbers of Treg and MDSC in the tumor. The gene discussed is CD4; the disease is neoplasm.